Β-Galactosidase CRISPR/Cas9 KO Plasmid

<strong>β-Galactosidase CRISPR/Cas9 KO Plasmid</strong>_x000D_ <strong>Catalog number:</strong> B2014926_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> β-Galactosidase CRISPR/Cas9 KO Plasmid_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Watanabe S, Sakurai T, Nakamura S, Miyoshi K, Sato M. The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones Int J Mol Sci. 2018 Apr 4;19(4):1075._x000D_ 2: Jeon S, Kim MM. The down-regulation of melanogenesis via MITF and FOXO1 signaling pathways in SIRT1 knockout cells using CRISPR/Cas9 system J Biotechnol. 2021 Dec 10;342:114-127._x000D_ 3: Maggio J, Cardama GA, Armando RG, Balcone L, Sobol NT, Gomez DE, Mengual Gómez DL. Key role of PIN1 in telomere maintenance and oncogenic behavior in a human glioblastoma model Oncol Rep. 2023 May;49(5):91._x000D_ 4: Ziegler H, Nellen W. CRISPR-Cas experiments for schools and the public Methods. 2020 Feb 1;172:86-94._x000D_ 5: Watzlawick H, Altenbuchner J. Multiple integration of the gene ganA into the Bacillus subtilis chromosome for enhanced β-galactosidase production using the CRISPR/Cas9 system AMB Express. 2019 Sep 30;9(1):158._x000D_ 6: Tang Z, Hegde S, Zhao J, Zhu S, Johnson KA, Lorson CL, Wang J. CRISPR-Mediated Enzyme Fragment Complementation Assay for Quantification of the Stability of Splice Isoforms Chembiochem. 2022 May 4;23(9):e202200012._x000D_ 7: de Maat V, Stege PB, Dedden M, Hamer M, van Pijkeren JP, Willems RJL, van Schaik W. CRISPR-Cas9-mediated genome editing in vancomycin-resistant Enterococcus faecium FEMS Microbiol Lett. 2019 Nov 1;366(22):fnz256._x000D_ 8: Inturi R, Jemth P. CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells Virology. 2021 Oct;562:92-102._x000D_ 9: Tan SZ, Reisch CR, Prather KLJ. A Robust CRISPR Interference Gene Repression System in Pseudomonas J Bacteriol. 2018 Mar 12;200(7):e00575-17._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/30817646">10: Zhao R, Kaakati R, Liu X, Xu L, Lee AK, Bachelder R, Li CY, Hollenbeck ST. CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression Plast Reconstr Surg. 2019 Mar;143(3):747-756. </a>_x000D_ _x000D_ <strong>Products Related to β-Galactosidase CRISPR/Cas9 KO Plasmid can be found at</strong> <a href="https://moleculardepot.com/product-category/DNA/"> DNA</a>